Positive Interim Results on Trontinemab Validate Brainshuttle Technology for Alzheimer Disease Treatment
Psychiatric Times
APRIL 4, 2025
Does trontinemab represent the next generation of anti-amyloid monoclonal antibodies thanks to Brainshuttle technology? New research looks encouraging.
Let's personalize your content